Farmaco

What Farmaco does

Farmaco is a Brazilian private startup founded by pharmacist Eugênio Neves, who holds master's and doctorate degrees and has over 25 years of experience building medication information technology systems. The company provides a validated, continuously updated database of medications commercialized in Brazil, covering pharmaceutical, therapeutic, and economic domains — including pharmaceutical forms, concentrations, manufacturers, therapeutic classifications, government-regulated prices, market prices, and defined average dose costs. Its core purpose is to consolidate fragmented Brazilian medication information into a single standardized resource that addresses the dynamism of the pharmaceutical market and the instability it creates for downstream users.

The company's product architecture is a dual SaaS and APIaaS platform. The SaaS product enables professionals and institutions to research medication substitution options, compare pharmaceutical forms and manufacturers, review regulatory and storage information, and run profitability analyses. The APIaaS offering delivers programmatic access to the same validated dataset for enterprises that need to integrate medication data into their own systems, explicitly framed as a stability solution for businesses whose core operations depend on reliable medication information. Distribution is direct-to-enterprise via WhatsApp Business, an inquiry form, and organic presence on Instagram and LinkedIn.

Farmaco serves the broader Brazilian pharmaceutical ecosystem — pharmacies, pharmaceutical companies, healthcare institutions, and medical professionals — through subscription-based recurring revenue on both products. The company is headquartered in São Paulo, was accelerated by Brazilian startup accelerator Inovativa, and discloses no external funding rounds, no named enterprise customers, and no public pricing, indicating an early-stage, bootstrapped operating profile with limited public transparency.

Name

Farmaco

Legal name

Farmaco

Website

https://farmaco.io

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Farmaco is a Brazilian startup that provides a validated, continuously updated medication database for Brazil through a SaaS platform and APIaaS, serving pharmacies, pharmaceutical companies, healthcare institutions, and medical professionals.

Ownership category

akta.pro rank

Product category

Pharmaceutical Data & Analytics

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Data Management, Reporting & Regulatory Submissions for Central Labs (HLAGAEAL)

Keywords

• Pharmaceutical data platform
• Medication information database
• Pharmaceutical SaaS
• Drug pricing analytics
• Healthcare data API

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS Subscription: Software as a Service subscription providing access to medication information platform for professionals and institutions to research medication substitution options, pharmaceutical forms, manufacturers, price variations, regulatory aspects, storage information, and profitability analysis.
2. APIaaS (API as a Service): API access service for companies needing a validated and updated medication database in Brazil, enabling integration into their existing systems for real-time medication data access.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Farmaco provides a validated, organized, standardized, and consolidated database of medications commercialized in Brazil, covering pharmaceutical, therapeutic, and economic domains. Customers access this database through a SaaS web application or via APIaaS integration, enabling them to quickly research medication substitution options, pharmaceutical forms, manufacturers, prices, regulatory aspects, storage information, and profitability analysis.

Product overview

Farmaco is a medication information platform that operates as a unified platform-plus-API architecture. The core offering consists of the SaaS platform, which provides pharmaceutical analysis, therapeutic analysis, and economic analysis tools for medication data, and the APIaaS service, which delivers programmatic access to Farmaco's validated and continuously updated Brazilian medication database for enterprise integration needs.

Differentiator

Problem solved

Functional benefit

Products and services

• SaaS (Software as a Service) SaaS web application that helps professionals and institutions research medication substitution options, pharmaceutical forms, medication manufacturers, price variations per medication, regulatory aspects, storage information, medication profitability analysis, and more.
• APIaaS (API as a Service) Application Programming Interface as a Service that enables companies to access Farmaco's validated and updated database of medications commercialized in Brazil through programmatic integration into their existing systems, addressing the dynamism of the Brazilian medication market.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• InovativacoreOthersInovativa is a Brazilian startup accelerator that has supported Farmaco. Farmaco is identified as an 'Empresa acelerada' (accelerated company) by Inovativa, indicating startup acceleration and mentorship support.

Scale indicators1 record

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Elsevier (Clinical Solutions / ClinicalPath): Elsevier provides clinical drug reference databases and decision-support tools (e.g., Clinical Pharmacology, Gold Standard) for healthcare professionals and institutions. It is comparable to Farmaco because it sells validated medication data via SaaS and integrated platforms to the same healthcare and pharmaceutical ecosystem.
• IQVIA: IQVIA is a global leader in healthcare data, analytics, and pharmaceutical market intelligence. It is comparable to Farmaco because it provides validated pharmaceutical data, pricing benchmarks, and drug information services globally, including in Brazil, representing a much broader incumbent competitor in the same end-market.
• Wolters Kluwer (Medi-Span / UpToDate Lexidrug): Wolters Kluwer operates Medi-Span and UpToDate Lexidrug, industry-standard pharmaceutical pricing and drug information databases used globally. It is comparable to Farmaco because it serves the same need for validated pharmaceutical, therapeutic, and pricing data via subscription and API access to healthcare enterprises.

Others

• Pague Menos / RD Saúde pharmacy chains: Large Brazilian pharmacy chains such as Pague Menos and RD Saúde operate extensive pharmacy networks with proprietary systems that handle medication substitution, pricing, and profitability analysis. They are comparable to Farmaco as potential enterprise API customers (integrators of validated medication data) rather than direct competitors, representing distribution and integration counterparties.
• ANVISA (Brazilian Health Regulatory Agency): ANVISA is the Brazilian federal regulatory agency that publishes official medication registrations, regulated prices (CMED), and labeling data. It is comparable to Farmaco as a baseline data source — Farmaco's economic analysis feature explicitly references government-regulated prices — meaning ANVISA is both an upstream data dependency and a potential substitute for some use cases.

Direct peers

• Memed: Memed is a leading Brazilian digital prescription and pharmaceutical information platform. It directly compares to Farmaco because it serves the same Brazilian pharmaceutical ecosystem with validated medication data, integrates with pharmacies and healthcare professionals, and provides pricing and substitution information through its software platform.
• MIMS (Monthly Index of Medical Specialities): MIMS is a multinational medication reference and prescribing database used by clinicians in Asia-Pacific and other regions. It is comparable to Farmaco because it aggregates and validates medication information across pharmaceutical, therapeutic, and pricing dimensions and delivers it through digital platforms to healthcare professionals and institutions.
• DrugBank: DrugBank is a structured pharmaceutical knowledge database offered via web and API access. It is comparable to Farmaco because it provides validated, structured medication data (chemical, pharmaceutical, and economic) and exposes it programmatically via APIs for enterprise integration — a near-parallel APIaaS model.
• Consulta Remédios: Consulta Remédios is a Brazilian medication price comparison and information platform used by consumers and pharmacies. It is comparable to Farmaco because it operates a validated Brazilian medication database, surfaces pricing and formulation data, and targets pharmacy and pharmaceutical ecosystem customers in the same geography.
• Vidal (VIDAL Group): Vidal is a French medication database and clinical decision support provider offering validated drug information to healthcare professionals. It is comparable to Farmaco because it delivers a curated medication database (pharmaceutical, therapeutic, and economic dimensions) via SaaS-style access to clinicians, with similar functional scope and business model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/farma-co
• Instagraminstagram.com/farmaco.io?igshid=dnJka2V3MjA2aGE1

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farmaco